Anti-allergic effect of intranasal administration of type-A procyanidin polyphenols based standardized extract of cinnamon bark in ovalbumin sensitized BALB/c mice
This study showed that 57% of individuals on Zepbound had more than a 20% reduction in body weight after 72 weeks of treatment
The simulation showed and confirmed that TIR (Fig
This result indicates that chronic treatment with GLP-1R agonists could lead to proliferation/chronic activation of PSCs, with serious side effects
Most patients benefit from GLP-1 medications like semaglutide or tirzepatide, but we choose based on your medical profile, insurance coverage, and treatment goals
Health care professionals should be aware that FDA found no increased risk of SI/B with the use of GLP-1 RA medications and is requesting the removal of this Warning and Precaution from the prescribing information for the GLP-1 RA medications (Saxenda, Wegovy, and Zepbound) that include such language